BDI reps are on-call for your emergency and after-hours
needs,
as well. Call 1-800-948-9834
for more information or to place an order
today.
Contact BDI
BDI Pharma is a Verified-Accredited Wholesale Distributor one
of 33 active members of the HDMA, and a
member of HISCI. Always rest assured your product is being handled
with the utmost care and professionalism.
Effective April 1, 2013 through June 30, 2013. Visit the Centers for Medicare
& Medicaid Services for more information.
|
|
Oxaliplatin Injection
General Information: Oxaliplatin is typically utilized in combination with infusional 5 fluorouracil/leucovorin in adjuvant treatment of colon cancer and the treatment of advanced colorectal cancer. For indication, dosing or other information, please refer to the manufacture package insert.
|
| |
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
| Pfizer |
Oxaliplatin |
50mg-10mL |
00069-0074-01 |
PI |
MSDS |
| |
|
100mg-20mL |
00069-0070-01 |
PI |
MSDS |
| Sagent |
Oxaliplatin
(Lyophillized) |
50mg-10mL |
25021-0211-20 |
PI |
MSDS |
| |
|
100mg-50mL |
25021-0212-50 |
PI |
MSDS |
| Caraco |
Oxaliplatin |
50mg |
47335-0176-40 |
PI |
MSDS |
| |
|
100mg |
47335-0178-40 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Oxaliplatin Injection, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|